Strides Pharma Detail
As per the Company website it is a global pharmaceutical Company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging Markets.
Strides has global manufacturing foot print with 7 manufacturing facilities spread across three continents including 5 US FDA approved facilities and 2 facilities for the emerging markets.
Below are different categories in which Company has divided its operation
- Pharma Generic
- It is one of the leading players worldwide in soft gel capsules.
- The market for this segment is North America, Australia and other regulated market.
- Product range is General Tablets, Hard and Soft Gelatine capsules, Sachets, Semi slids, Ointment, Creams and Potent drugs
- Branded Generics
- The target marker for this segment is Africa.
- Institutional Business
- It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis and other infectious disease drug segments for our institutional business
I have shared long term price performance chart of the Company below.As per Dow theory of technical analysis price performance over a period of time reflects Company state.
Strides Pharma Stock Performance
The stock has struggled in recent times due to USFDA issues. Note last few years were not good for Indian Pharma industry because of FDA issues. Most of the Pharma companies have struggled in these times. They are trading at multi year low or have corrected from their highs created before.
Except the recent times it has performed well for investors. The second huge dive just before year 2015 is because of hefty dividend paid by the Company. If we leave out that dividend it has performed well for investors over the years.
The dividend yield of the Company is good and it has paid good dividends in past as well.
Strides Pharma My Opinion
Strides Pharma is an Pharma Company. The Company devised its strategy based on Regions and rules and regulations governing the regions. The market of Africa is not that strictly regulated compared to market of US. So it has two different strategy for these two markets.
It has divided the business areas into Generic and Branded depending upon the region it has focus on.I kind of liked this approach. Company has performed well for years but it is struggling as of now. Recently it has also demerged some of its API business to integrate with Sequent Sciences which gave birth to new Company Solara Active Pharma Sciences.
This Company was once on my radar due to its performance and focused approach towards the business. But too many mergers and demergers is something I disliked about it. I did have exposure to Pharma Company but not this Company. As of now I am not tracing it as there are better picks available in market compared to this one.
In case you are interested then you can track the company by adding it to your stock watch list. That way you can keep close eye on the Company.